David N. Gill

Director at Y-mAbs Therapeutics · 4 reported transactions in 2 companies · latest report Feb 17, 2026

Their trades

Share awardEvolus

Feb 17, 2026 · EOLS

45,559

Sep 16, 2025 · YMAB

25,080

Sep 16, 2025 · YMAB

$50.1K

Jun 30, 2025 · YMAB

25,080

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Y-mAbs Therapeutics · 4 reported transactions in 2 companies · latest report Feb 17, 2026